Home
    • Plans Blog Contact
    Heart Test Laboratories Inc Unit logo

    Heart Test Laboratories Inc Unit

    HSCS
    Last price US$2.43
    Market cap US$3.1m
    12M price change -37.00%
    Loading the 12-month Mave Thesis and 1-month news signal

    Industry and sector peers, plus broader research alternatives

    View comparison
    Abbott LaboratoriesABT Industry peer DexCom IncDXCM Industry peer Edwards Lifesciences CorpEW Industry peer Zoetis IncZTS Sector peer
    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    Heart Test Laboratories Inc Unit Overview

    Industry: Medical Devices

    Sector: Healthcare

    Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas. Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG inform Read More

    Mavefund brings filings, fundamentals, valuation, price history and news for Heart Test Laboratories Inc Unit into one research view. The sections below show what strengthens or weakens the research case.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed Mar 16, 2026

    Quarterly result summary

    ex_933272.htm Exhibit 99.1 HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update Southlake, Texas — March 16, 2026 — HeartSciences Inc. (Nasdaq: HSCS), a healthcare information technology (“HIT”) company focused on adv...

    What changed

    • Review the SEC source filing for the full reported results and management commentary.

    Guidance / outlook

    Management expects to announce several key customer wins during 2026. ● AI-ECG marketplace opportunity.

    Earnings release Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing FORM 10-K Jul 23, 2026 SEC filing FORM 8-K Mar 16, 2026 SEC filing FORM 10-Q Mar 16, 2026 SEC filing 8-K Dec 15, 2025 Earnings release Earnings release Dec 15, 2025 SEC filing 10-Q Dec 15, 2025 Earnings release Earnings release Sep 11, 2025 SEC filing 8-K Sep 11, 2025 SEC filing 10-Q Sep 11, 2025 Earnings release Earnings release Jul 24, 2025 SEC filing 8-K Jul 24, 2025

    Prediction-grade evidence

    Recent News

    Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

    Earnings Per Share

    Score 0.00/5
    Heart Test Laboratories Inc Unit earns a low score, as its Earnings Per Share (EPS) has not shown continuous growth over the last six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    In Medical Devices industry , Abbott Laboratories , DexCom Inc , Edwards Lifesciences Corp are companies with high ratings.

    Return on Equity

    Score 4.02/5
    Heart Test Laboratories Inc Unit stands out with a superior score in the Return on Equity (ROE) section, surpassing the sector median value and showcasing its strong performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    Heart Test L... HSCS US$3.1m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Net Margin

    Score 4.33/5
    Heart Test Laboratories Inc Unit commands a high score, propelled by its net margin consistently outpacing the sector median value and exhibiting continuous growth in recent six years; noteworthy counterparts in the sector, boasting similarly high scores, include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    Heart Test L... HSCS US$3.1m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Share Buyback

    In Medical Devices industry , Abbott Laboratories , DexCom Inc , Edwards Lifesciences Corp are companies with high ratings.

    Leverage

    Score 4.74/5
    Heart Test Laboratories Inc Unit attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc , also exhibit high scores.
    Heart Test L... HSCS US$3.1m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    Verified SEC statements load when this section enters view.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    Heart Test Laboratories Inc Unit logo

    Heart Test Laboratories Inc Unit

    US$2.43

    US$3.1m

    -8.12%

    -37.00%